Biohaven Ltd. (BHVN)
NYSE: BHVN · Real-Time Price · USD
22.60
-1.44 (-5.99%)
At close: Apr 1, 2025, 4:00 PM
22.89
+0.29 (1.28%)
After-hours: Apr 1, 2025, 8:00 PM EDT
Biohaven Market Cap
Biohaven has a market cap or net worth of $2.31 billion as of April 1, 2025. Its market cap has decreased by -49.94% in one year.
Market Cap
2.31B
Enterprise Value
1.86B
1-Year Change
-49.94%
Ranking
Category
Stock Price
$22.60
Market Cap Chart
Since October 18, 2022, Biohaven's market cap has increased from $412.66M to $2.31B, an increase of 458.92%. That is a compound annual growth rate of 101.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2025 | 2.45B | -35.04% |
| Dec 31, 2024 | 3.78B | 9.99% |
| Dec 29, 2023 | 3.43B | 262.97% |
| Dec 30, 2022 | 946.07M | 129.26% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.66B |
| UnitedHealth Group | 479.08B |
| Johnson & Johnson | 399.65B |
| AbbVie | 370.64B |
| Novo Nordisk | 302.16B |
| Abbott Laboratories | 230.06B |
| Merck & Co. | 226.74B |
| AstraZeneca | 225.46B |